MXCT
MaxCyte, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.28
+1.59%Margins
Gross margin
79.4%
EBITDA margin
-104.5%
EBIT margin
-111.6%
Net margin
-114.8%
FCF margin
-76.6%
-22.4%
Return on equity
-19.3%
Return on assets
-19.7%
Return on invested capital
0.16x
Asset turnover
-$23.0M
Cash from operations
$1.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026